BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 31696811)

  • 21. Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents.
    Mohamed-Ezzat RA; Srour AM
    Anticancer Agents Med Chem; 2024; 24(7):544-557. PubMed ID: 38204260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
    Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
    Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
    Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
    Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
    Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
    Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
    Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.
    Wang G; Qiu J; Xiao X; Cao A; Zhou F
    Bioorg Chem; 2018 Feb; 76():249-257. PubMed ID: 29197743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
    Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
    Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
    Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A
    Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
    Ethiraj KR; Aranjani JM; Khan FR
    Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 3',5'-diprenylated chalcones inhibited the proliferation of cancer cells in vitro by inducing cell apoptosis and arresting cell cycle phase.
    Wen Z; Zhang Y; Wang X; Zeng X; Hu Z; Liu Y; Xie Y; Liang G; Zhu J; Luo H; Xu B
    Eur J Med Chem; 2017 Jun; 133():227-239. PubMed ID: 28390228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
    Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
    Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines.
    Sangpheak K; Mueller M; Darai N; Wolschann P; Suwattanasophon C; Ruga R; Chavasiri W; Seetaha S; Choowongkomon K; Kungwan N; Rungnim C; Rungrotmongkol T
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):134-143. PubMed ID: 30394113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
    Gibson MZ; Nguyen MA; Zingales SK
    Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
    Ghanaat J; Khalilzadeh MA; Zareyee D
    Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.
    Mohamed MF; Mohamed MS; Fathi MM; Shouman SA; Abdelhamid IA
    Anticancer Agents Med Chem; 2014; 14(9):1282-92. PubMed ID: 25323033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The products of the reaction between 6-amine-1,3-dimethyl uracil and bis-chalcones induce cytotoxicity with massive vacuolation in HeLa cervical cancer cell line.
    Solano JD; González-Sánchez I; Cerbón MA; Guzmán Á; Martínez-Urbina MA; Vilchis-Reyes MA; Martínez-Zuñiga EC; Alvarado C; Quintero A; Díaz E
    Eur J Med Chem; 2013 Feb; 60():350-9. PubMed ID: 23314048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.
    Bazzaro M; Anchoori RK; Mudiam MK; Issaenko O; Kumar S; Karanam B; Lin Z; Isaksson Vogel R; Gavioli R; Destro F; Ferretti V; Roden RB; Khan SR
    J Med Chem; 2011 Jan; 54(2):449-56. PubMed ID: 21186794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Antiproliferative and Cytotoxic Activities, DNA Binding Features and Molecular Docking Study of Novel Enamine Derivatives.
    Burcu Gürdere M; Aydin A; Yencilek B; Ertürk F; Özbek O; Erkan S; Budak Y; Ceylan M
    Chem Biodivers; 2020 Jul; 17(7):e2000139. PubMed ID: 32374947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
    Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
    Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis.
    Bustos L; Echiburú-Chau C; Castro-Alvarez A; Bradshaw B; Simirgiotis MJ; Mellado M; Parra C; Cuellar M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.